Cardiology Medical News about MS;B-typenatriuretic peptide;subclinical heart injury;mitoxantrone therapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients—Preliminary study
Clinical Neurology and Neurosurgery, 08/31/09

Luchowski P et al. – The results strongly suggest subclinical myocardial dysfunction in mitoxantrone–treated group. We assume, that low–cost, repeated BNP measurements may be a good alternative for detection of early subtle myocardial injury in MS patients during routine mitoxantrone therapy.

<< Previous
Atrial Arrhythmias following Lung Transplantation: Epidemiology,...

Next >>
Prolonged Electrocardiogram QRS Duration Independently Predicts...